AQR Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-188,386
| Closed | -$712K | – | 3153 |
|
|
2024
Q4 | $712K | Sell |
188,386
-460,693
| -71% | -$1.74M | ﹤0.01% | 2071 |
|
|
2024
Q3 | $2.1M | Sell |
649,079
-2,691,864
| -81% | -$8.72M | ﹤0.01% | 1482 |
|
|
2024
Q2 | $6.35M | Buy |
3,340,943
+3,224,454
| +2,768% | +$6.13M | 0.01% | 923 |
|
|
2024
Q1 | $331K | Buy |
116,489
+93,145
| +399% | +$265K | ﹤0.01% | 2100 |
|
|
2023
Q4 | $344K | Sell |
23,344
-295
| -1% | -$4.34K | ﹤0.01% | 2020 |
|
|
2023
Q3 | $433K | Buy |
23,639
+9,408
| +66% | +$172K | ﹤0.01% | 1896 |
|
|
2023
Q2 | $307K | Buy |
14,231
+6,384
| +81% | +$138K | ﹤0.01% | 1930 |
|
|
2023
Q1 | $230K | Buy |
+7,847
| New | +$230K | ﹤0.01% | 2017 |
|